Information On Prolonged Seizures
Optimal Treatment Of Prolonged Acute Convulsive Seizure
**p-value = 0.16
Abend NS, Marsh E. Convulsive and nonconvulsive status epilepticus in children. Current Treatment Options in Neurology. 2009 Jul 1;11(4):262-72
Ashrafi MR, Khosroshahi N, Karimi P, Malamiri RA, Bavarian B, Zarch AV, Mirzaei M, Kompani F. Efficacy and usability of buccal midazolam in controlling acute prolonged convulsive seizures in children. European Journal of Paediatric Neurology. 2010 Sep 1;14(5) :434-8
Lagae L. Clinical practice. European Journal of Pediatrics. 2011 Apr 1;170(4):413-8
British Medical Journal. Status epilepticus. Available from: https://bestpractice.bmj.com/topics/en-gb/464 (accessed 03 Apr 2020)
Scott RC, Besag FM, Neville BG. Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomised trial. The Lancet. 1999 Feb 20;353(9153):623-6.
Novorol CL, Chin RF, Scott RC. Outcome of convulsive status epilepticus: a review. Archives of Disease in Childhood. 2007 Nov 1;92(11):948-51
National Institute for Health and Care Excellence (NICE). Epilepsies: Diagnosis and Management. Available from: https://www.nice.org.uk/guidance/cg137/chapter/1-Guidance#prolonged-or-repeated-seizures-and-convulsive-status-epilepticus-2 (accessed 03 Apr 2020)
Pellock JM. Overview: definitions and classifications of seizure emergencies. Journal of Child Neurology. 2007 May;22(5_suppl):9S-13S
BUCCOLAM SmPC. Available from: https://www.medicines.org.uk/emc/product/7460 (accessed 03 Apr 2020)
Hartman AL, Devore CD. Rescue medicine for epilepsy in education settings. Pediatrics. 2016 Jan 1;137(1):e20153876″
This information is provided as a resource to HCP’s who prescribe or administer Buccolam.
Reporting of adverse events (Healthcare Professionals in the UK)
Adverse events should be reported. Reporting forms and information can be found at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Neuraxpharm. at: email@example.com